Endothelin-Receptor Blockade in Coronary Heart Disease
Status:
Completed
Trial end date:
2006-08-01
Target enrollment:
Participant gender:
Summary
Endothelin is a hormon that causes acute and chronic narrowing of heart vessels. The purpose
of this study is to assess whether suppression of this activity by using two types of
receptor antagonists can reduce this effect and thus improve blood supply of the heart
muscle.